Compare Core Scientific Inc (CORZ) vs Raytheon Technologies Corp (RTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Core Scientific Inc vs Raytheon Technologies Corp — how do they compare? Core Scientific Inc trades at $15.28 (market cap $4.94B), while Raytheon Technologies Corp trades at $185.45 (market cap $248.42B). The key difference: Raytheon Technologies Corp is far larger — about 50.3× Core Scientific Inc's market cap, and Raytheon Technologies Corp pays a 1.58% dividend while Core Scientific Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Core Scientific Inc for 20 Days and Raytheon Technologies Corp for 77 Days on average.
| CORZ | RTX | |
|---|---|---|
Market Cap | $4.94B | $248.42B |
Volume | 15,630,800 | 4,380,368 |
Sector | Technology | Industrials |
52-Week High | $29.16 | $225.49 |
52-Week Low | $13.57 | $157.00 |
Typical Hold Time | 20 Days | 77 Days |
Enterprise Value | $7.46B | $278.97B |
Dividend Yield | — | 1.58% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Core Scientific (CORZ) trades at $15.30, down 4.02% today amid bearish technical signals and negative earnings momentum. The stock faces fundamental challenges with a net income margin of -324.9% and three consecutive quarterly earnings misses. However, analyst sentiment remains overwhelmingly positive with 86% buy ratings and a $32.75 consensus price target, while recent executive appointments and AI infrastructure developments provide potential catalysts.
Despite current financial struggles, CORZ shows potential through its pivot to AI data center services and strong institutional support. Key risks include persistent negative profitability, high capital expenditures, and cryptocurrency market volatility. The significant gap between current price and analyst targets suggests upside potential if the company executes its AI infrastructure strategy successfully.
RTX trades at $180.26, down 1.65% today, amid a bearish technical signal but strong fundamental performance. The company reported three consecutive quarterly earnings beats, with Q3 2026 EPS expected at $1.77. Revenue grew to $88.6B in 2025, with net income margin improving to 7.59%. Analyst consensus remains strongly bullish with a $236.27 price target and 65% buy ratings, supported by a $289B backlog and defense sector tailwinds.
The outlook for RTX is positive given robust defense spending, earnings momentum, and analyst confidence. Risks include execution on large contracts, debt levels, and geopolitical uncertainties. The stock offers growth potential with a 30% upside to consensus target, but investors should monitor quarterly execution and defense budget developments.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Core Scientific Inc
Core Scientific provides digital infrastructure for Bitcoin mining and high-performance computing (HPC). It operates purpose-built data centers to support digital asset production and AI-related workloads.
Read more on CORZ →About Raytheon Technologies Corp
Raytheon Technologies is a diversified aerospace and defense industrial company formed from the merger of United Technologies and Raytheon, with roughly equal exposure as a supplier to commercial aerospace manufactures and to the defense market as a prime and subprime contractor.
Read more on RTX →
